| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/08/2006 | WO2006094095A2 Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner |
| 09/08/2006 | WO2006093529A2 Covalent tethering of functional groups to proteins and substrates therefor |
| 09/08/2006 | WO2006093277A1 Soybean transformant having functional peptide therein and use of the same |
| 09/08/2006 | WO2006093222A1 Inhibitor for insulin polymer formation |
| 09/08/2006 | WO2006093088A1 Novel polypeptide, polynucleotide encoding the polypeptide and use the polypeptide and polynucleotide |
| 09/08/2006 | WO2006093030A1 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
| 09/08/2006 | WO2006092515A1 Transgenic mice and use thereof as an experimental model |
| 09/08/2006 | WO2006092338A2 Tnf-alpha binding polypeptide , uses thereof and methods employing it |
| 09/08/2006 | WO2006067402A3 Agents inibiting the cathelin-like protein cap18/ll-37 |
| 09/08/2006 | WO2006052723A3 G protein coupled receptor agonists and antagonists and methods of use |
| 09/08/2006 | WO2006050984A3 Recombinant newcastle disease virus |
| 09/08/2006 | WO2006050244A3 Treatment of short bowel syndrome patients with colon-in-continuity |
| 09/08/2006 | WO2006047417A3 Detection of cannabinoid receptor biomarkers and uses thereof |
| 09/08/2006 | WO2006044596A3 Multi-domain amphipathic helical peptides and methods of their use |
| 09/08/2006 | WO2006042847A3 Method for the preparation of oxime, thiazolidine, dithiane, dithiolane or hydrazone linked analogues of growth hormone |
| 09/08/2006 | WO2006039652A3 Chondroitin sulfate a binding domains |
| 09/08/2006 | WO2006037810A3 Protracted glp-1 compounds |
| 09/08/2006 | WO2006029891A3 Change of the load state of mhc molecules |
| 09/08/2006 | WO2006029224A3 Methods of using death receptor ligands and cd20 antibodies |
| 09/08/2006 | WO2005051299A3 Metalloproteinase-binding proteins |
| 09/08/2006 | WO2005025517A3 Animal model for protease activity and liver damage |
| 09/08/2006 | WO2005010035A3 Alternate reading frame polypeptides derived from hepatitis c and methods of their use |
| 09/08/2006 | WO2004053066A3 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 09/08/2006 | WO2004029071A3 Mage-c2 antigenic peptides and uses thereof |
| 09/08/2006 | WO2003062385A3 Secretory molecules |
| 09/08/2006 | CA2608859A1 New sources for, and types of, insecticidally active proteins, and polynucleotides that encode the proteins |
| 09/08/2006 | CA2600912A1 Transgenic mice and use thereof as an experimental model |
| 09/08/2006 | CA2599743A1 A method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom |
| 09/08/2006 | CA2599740A1 A method for identifying skin care composition-resistant skin-binding peptides |
| 09/08/2006 | CA2599731A1 Quantification of proteins |
| 09/08/2006 | CA2599613A1 Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner |
| 09/08/2006 | CA2599240A1 Fgf growth factor analogs |
| 09/08/2006 | CA2599004A1 Anti-angiogenic methods and compositions |
| 09/08/2006 | CA2575611A1 Covalent tethering of functional groups to proteins and substrates therefor |
| 09/07/2006 | WO2006069220A9 Modified human growth hormone |
| 09/07/2006 | US20060200879 Heat and cold tolerance in plants; increasing abiotic stress tolerance in yeast comprising transforming yeast with a nucleic acid sequence encoding the protein |
| 09/07/2006 | US20060199969 Method for obtaining an oil fraction and a protein fraction from a vegetable starting substance |
| 09/07/2006 | US20060199949 Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
| 09/07/2006 | US20060199947 Naturally-occurring variants of B7 proteins produced by alternative RNA splicing or alternative termination of full-length amino acid sequence; regulation of immune response in an animal; immunostimulants; anticarcinogenic agents, infections; antiallergens; antiinflammatory agents; veterinary medicine |
| 09/07/2006 | US20060199946 Apoptosis inducing agent and method for inducing apoptosis |
| 09/07/2006 | US20060199781 Assays based on BTF3 activity |
| 09/07/2006 | US20060199777 Novel technology of intracellular delivery of dna oligonucleotides to improve drug activity |
| 09/07/2006 | US20060199769 Alpha-fetoprotein peptides and uses thereof |
| 09/07/2006 | US20060199765 PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 09/07/2006 | US20060199764 FGF growth factor analogs |
| 09/07/2006 | US20060199763 Derivatives of GLP-1 analogs |
| 09/07/2006 | US20060199759 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 09/07/2006 | US20060199250 Method for generating a mutant protein which efficiently binds a target molecule |
| 09/07/2006 | US20060199249 Method for protein production |
| 09/07/2006 | US20060199248 Q3 SPARC deletion mutant and uses thereof |
| 09/07/2006 | US20060199247 Method for identifying modulators gene expression |
| 09/07/2006 | US20060199246 Zinc-regulated prokaryotic expression cassettes |
| 09/07/2006 | US20060199241 Co-factor labeled protein, a co-factor labeled peptide, or a co-factor labeled oligonucleotide; exposing to exonuclease activity, hydrolyzing the oligonucleotide, releasing a fragment of the oligonucleotide including the co-factor of pyrroloquinoline quinone |
| 09/07/2006 | US20060199228 Peptides for treatment of autoimmune diseases |
| 09/07/2006 | US20060199225 Modified chitin binding domain and uses thereof |
| 09/07/2006 | US20060199195 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 09/07/2006 | US20060199190 Detection and typing of bacterial strains |
| 09/07/2006 | US20060199186 Optical monitoring of cleaving enzyme activity |
| 09/07/2006 | US20060199184 Fusion protein is a partial fragment of developmentally regulated endothelial cell locus-1 (Del-1) protein; gene expression; drug delivery; side effect reduction |
| 09/07/2006 | US20060199181 Compositions and methods for the treatment of immune related diseases |
| 09/07/2006 | US20060199180 Compositions and methods relating to ovarian specific genes and proteins |
| 09/07/2006 | US20060199177 T helper cell epitopes |
| 09/07/2006 | US20060199176 Coronavirus S peptides |
| 09/07/2006 | US20060198855 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 09/07/2006 | US20060198853 Papilloma virus capsomere vaccine formulations and methods of use |
| 09/07/2006 | US20060198852 Collagen-binding MSCRAMMs of Bacillus anthracis and uses therefor |
| 09/07/2006 | US20060198841 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 09/07/2006 | US20060198840 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 09/07/2006 | US20060198833 Compositions and methods for targeting a polypeptide to the central nervous system |
| 09/07/2006 | US20060198831 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 09/07/2006 | US20060198826 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 09/07/2006 | US20060198820 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 09/07/2006 | US20060198819 Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest |
| 09/07/2006 | US20060198793 Antimicrobial polypeptide, nucleic acid, and methods of use |
| 09/07/2006 | US20060198785 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes |
| 09/07/2006 | US20060198784 Methods of treatment using antibodies to Neutrokine-alpha |
| 09/07/2006 | DE102005009784A1 Peptid-Mimetika und ihre Verwendung als Inhibitoren des 20S Proteasoms, 26S Proteasoms und Immunoproteasoms Peptide mimetics and their use as inhibitors of the 20S proteasome, the 26S proteasome and immunoproteasome |
| 09/07/2006 | DE102005008416A1 Verfahren zur Reinigung von marinem Kollagen sowie dessen Verarbeitung zu porösen Schwämmen A method for purifying marine collagen and the processing of porous sponges |
| 09/06/2006 | EP1698901A1 Method for detecting N-terminal proBNP |
| 09/06/2006 | EP1698898A2 Prognostic, diagnostic and therapeutic significance in detecting and using TIN-antigen (Tubulo-Interstitial nephritis antigen) and its segments |
| 09/06/2006 | EP1698699A2 Improved expression of CRY3B insecticidal protein in plants |
| 09/06/2006 | EP1698698A1 Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets the same |
| 09/06/2006 | EP1698697A2 SSD-containing protein, process for producing the same and use thereof |
| 09/06/2006 | EP1698696A1 Target protein of antidiabetic agent and novel antidiabetic agent insuful corresponding thereto |
| 09/06/2006 | EP1698694A1 Method of obtaining gene tag |
| 09/06/2006 | EP1698693A1 Royal jelly peptide and composition containing the same |
| 09/06/2006 | EP1698691A1 Growth factor mutants with improved biological activity |
| 09/06/2006 | EP1698639A2 Pluripotency determining factors and uses thereof |
| 09/06/2006 | EP1698636A1 Preparation of derivatized peptides from bile acids |
| 09/06/2006 | EP1698347A2 hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/06/2006 | EP1698346A1 Agent against malignant neuroglia and agent against malignant neuroglia for animals |
| 09/06/2006 | EP1698345A2 Peptide antagonists of zonulin and methods for use of the same |
| 09/06/2006 | EP1697751A2 Assay and treatment |
| 09/06/2006 | EP1697542A2 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 09/06/2006 | EP1697536A2 Novel oligonucleotides and treating cardiac disorders by using the same |
| 09/06/2006 | EP1697531A2 Process for preparing l-amino acids using strains of the enterobacteriaceae family |
| 09/06/2006 | EP1697530A1 Process for preparing l-amino acids using strains of the enterobacteriaceae family |
| 09/06/2006 | EP1697525A2 P ef-tu expression units |
| 09/06/2006 | EP1697524A1 Pgro expression units |
| 09/06/2006 | EP1697517A1 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |